Literature DB >> 21507639

SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei.

Joe B Perales1, Jennifer Freeman, Cyrus J Bacchi, Tana Bowling, Robert Don, Eric Gaukel, Luke Mercer, Joseph A Moore, Bakela Nare, Tien M Nguyen, Robert A Noe, Ryan Randolph, Cindy Rewerts, Stephen A Wring, Nigel Yarlett, Robert T Jacobs.   

Abstract

A series of 2,4-diaminopyrimidines was investigated and compounds were found to have in vivo efficacy against Trypanosoma brucei in an acute mouse model. However, in vitro permeability data suggested the 2,4-diaminopyrimidenes would have poor permeability through the blood brain barrier. Consequently a series of 4-desamino analogs were synthesized and found to have improved in vitro permeability.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507639     DOI: 10.1016/j.bmcl.2011.03.097

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.

Authors:  Tana Bowling; Luke Mercer; Robert Don; Robert Jacobs; Bakela Nare
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-03-03       Impact factor: 4.077

2.  Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(3-nitro-phen-yl)acetamide monohydrate and N-(2-chloro-phen-yl)-2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]acetamide.

Authors:  S Subasri; Ajay Kumar Timiri; Nayan Sinha Barji; Venkatesan Jayaprakash; Viswanathan Vijayan; Devadasan Velmurugan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-07-22

3.  2-[(4,6-Di-amino-pyrimidin-2-yl)sulfan-yl]-N-(2-methyl-phen-yl)acetamide.

Authors:  S Subasri; Timiri Ajay Kumar; Barji Nayan Sinha; Venkatesh Jayaprakash; Devadasan Velmurugan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.